The Food and Drug Adminstration (FDA) has announced a 30-day extension of the comment period for the proposed rule.
This week the FDA announced a six-month extension of the ingredient listing requirement for manufacturers and importers of newly “deemed”...
The FDA has delayed a deadline that was originally Nov. 8, 2019 for reporting the testing results for potentially harmful constituents in every cigar and pipe tobacco product sold in the United States.
FOR IMMEDIATE RELEASE - July 28, 2017 - WASHINGTON, D.C. - Today, Commissioner of the U.S. Food & Drug Administration, Dr. Scott Gottlieb, announced a new comprehensive plan for the approach the agency will take to the regulation of tobacco products, placing an emphasis on a science-based method, that notes a "continuum of risk" that recognizes the differences in tobacco products.
Earlier today the US House of Representatives passed a 12 bill spending package that includes a provision prohibiting the FDA from enforcing regulations against premium cigars. The bill, known as an omnibus appropriations package, passed the House by 211-198 votes and will now move to the Senate for consideration. Congress has until December 8th to pass spending legislation and fund the federal government.
The U.S. Food and Drug Administration on Thursday decided to choose Option 1 of the two proposed regulations on tobacco products, option 2 would have granted an exemption for premium cigars. Today, the FDA banned sales of e-cigarettes, cigars, pipe tobacco and hookah tobacco to people under age 18, in line with cigarette rules, a move aimed at preventing a new generation from becoming addicted to nicotine. The agency said it also will require companies to submit these products to it for regulatory review, provide it with a list of product ingredients and place health warnings on their product packages and in advertisements.
IPCPR previously reported that because the Food and Drug Administration (FDA) believes blending pipe tobacco is “manufacturing,” retailers that plan to continue blending pipe tobacco should register with the FDA by December 31, 2016. However, earlier today (December 9), FDA extended the December 31, 2016 deadline to June 30, 2017 in certain circumstances. CLICK HERE to view the revised guidance.
The FDA is taking another look at premium cigars in a move that anti-tobacco groups fear could weaken regulations. It's the latest push under Commissioner Scott Gottlieb to undertake a sweeping overall of tobacco and nicotine regulation. The FDA recently took the first step in lowering the amount of nicotine in cigarettes. It also said it's seeking information on the role flavors, including menthol, play in attracting people to tobacco products and alternatives like e-cigarettes.
Earlier today, D.C. District Court Judge Amit Mehta issued an injunction prohibiting the U.S. Food & Drug Administration from enforcing its warning label requirements on cigars and pipe tobacco. The warning label requirements for packaging and advertising were slated to go into effect on August 10th. Judge Mehta’s order delays any enforcement of the requirement until at least 60 days after the conclusion of an appeal currently underway. No date has been set for a court to hear the appeal.
On April 24, 2014, the U.S. Food and Drug Administration (FDA) released proposed regulations to extend the authority of the FDA's Center for Tobacco Products (CTP), under the Family Smoking Prevention and Tobacco Control Act, to additional tobacco products. This can have a major impact on the cigar industry along with the other tobacco products that the FDA is targeting.